Codexis Q2 revenue $14.9M, net loss $12.0M; reiterates FY guidance

CODEXIS, INC.

Q2 2026 revenue $14.9M vs $15.3M YoY; net loss $12.0M ($0.13/sh) vs $13.3M ($0.16/sh).
Product gross margin 73% vs 72% YoY; cash at June 30 was $54.9M.
Completed July equity raise of ~$25M net proceeds; proforma cash ~$80M.
Reiterated FY2026 revenue guidance of $72-76M; high 60% gross margin; cash runway through 2028.
TIDES US data showed ECO Synthesis stereoisomer control for siRNA; GMP facility permit application planned H2 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.